Schweitzer, F., Laurent, S., Fink, G. R., Barnett, Michael H., Hartung, H. P. and Warnke, C. . Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis. J. Neurol.. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1459
Full text not available from this repository.Abstract
Modern disease-modifying therapies (DMTs) in multiple sclerosis (MS) have variable modes of action and selectively suppress or modulate the immune system. In this review, we summarize the predicted and intended as well as unwanted adverse effects on leukocytes in peripheral blood as a result of treatment with DMTs for MS. We link changes in laboratory tests to the possible therapeutic risks that include secondary autoimmunity, infections, and impaired response to vaccinations. Profound knowledge of the intended effects on leukocyte counts, in particular lymphocytes, explained by the mode of action, and adverse effects which may require additional laboratory and clinical vigilance or even drug discontinuation, is needed when prescribing DMTs to treat patients with MS.
| Item Type: | Journal Article | ||||||||||||||||||||||||||||
| Creators: |
|
||||||||||||||||||||||||||||
| URN: | urn:nbn:de:hbz:38-345211 | ||||||||||||||||||||||||||||
| DOI: | 10.1007/s00415-019-09690-6 | ||||||||||||||||||||||||||||
| Journal or Publication Title: | J. Neurol. | ||||||||||||||||||||||||||||
| Publisher: | SPRINGER HEIDELBERG | ||||||||||||||||||||||||||||
| Place of Publication: | HEIDELBERG | ||||||||||||||||||||||||||||
| ISSN: | 1432-1459 | ||||||||||||||||||||||||||||
| Language: | English | ||||||||||||||||||||||||||||
| Faculty: | Unspecified | ||||||||||||||||||||||||||||
| Divisions: | Unspecified | ||||||||||||||||||||||||||||
| Subjects: | no entry | ||||||||||||||||||||||||||||
| Uncontrolled Keywords: |
|
||||||||||||||||||||||||||||
| URI: | http://kups.ub.uni-koeln.de/id/eprint/34521 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
 |
View Item |